Business
Apollo Biowellness, Inc., Launches New Product Brand
Apollo Biowellness, Inc., Launches New Product Brand.
About this update from Resonate Blends Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Apollo Biowellness, Inc., Launches New Product Brand\r\n \r\n \r\n\r\n\r\nApollo Biowellness, Inc., Launches New Product Brand\r\n\r\n\r\n\r\nNewsfile Corp.\r\n\r\n\r\nNewsfile Corp\r\n\r\n\r\nradeditorformatted_6North Bergen, New Jersey--(Newsfile Corp. - August 21, 2025) - Apollo Biowellness, Inc. (OTC Pink: KOAN) (the \"Company\"), is pleased to announce the launch of a new self-stable biologic cosmetic.\r\n\r\nFigure 1\r\nTo view an enhanced version of this graphic, please visit:\r\nhttps://images.newsfilecorp.com/files/10533/263268_a2b1b8e5841dc830_001full.jpg\r\nOur new brand is called Cielo Skin Care, and it is a full line of consumer products using self-stabilized exosome and placental based products using human tissue as its core ingredient. Using such molecules will maximize the regeneration and regrowth of skin cells, thus improving the anti-aging effect that comes from ageing, sun exposure and other skin damage.\r\nThe Cielo Skin Care line will be launched in the late third quarter and will go to market in the fourth quarter. It will launch in major retail, e-commerce, direct-to-consumer marketing and via social media influencers and TV shopping outlets.\r\nJames W. Zimbler, President and CEO, stated, \"We are proud to launch the FIRST shelf stable biologic skin care cosmetic. Coupled with our current Doctor and Med Spa brand, Evolutionary Biologics, we anticipate significant growth of our business model.\"\r\nThe Company uses the following handle on X at @ApolloBioKOAN to communicate with its shareholders\r\nAbout Apollo Biowellness, Inc.Apollo Biowellness, Inc., and its subsidiary, Evolutionary Biologics, Inc., is engaged in the discovery, development and marketing of products designed to better mankind. We believe we are positioning our company as a leader in the field of Regenerative Medicine as defined by the National Institute of Health using biologic based products. Intended products are to be marketed under third-party label exemptions. We are focusing our current efforts on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. Also, we are licensed under a patent-pending application to market a dual acting all-natural diet aid designed to help control hunger through...